P Fitscha

992 total citations
100 papers, 643 citations indexed

About

P Fitscha is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, P Fitscha has authored 100 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cardiology and Cardiovascular Medicine, 32 papers in Pharmacology and 28 papers in Surgery. Recurrent topics in P Fitscha's work include Antiplatelet Therapy and Cardiovascular Diseases (33 papers), Inflammatory mediators and NSAID effects (26 papers) and Lipoproteins and Cardiovascular Health (12 papers). P Fitscha is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (33 papers), Inflammatory mediators and NSAID effects (26 papers) and Lipoproteins and Cardiovascular Health (12 papers). P Fitscha collaborates with scholars based in Austria, Germany and United Kingdom. P Fitscha's co-authors include H. Sinzinger, John O’Grady, Irene Virgolini, J Kaliman, H Sinzinger, F Rauscha, W. Rogatti, G Hitzenberger, Thomas Zidek and Kelly Weiss and has published in prestigious journals such as The Lancet, Thrombosis and Haemostasis and Journal of Hypertension.

In The Last Decade

P Fitscha

96 papers receiving 583 citations

Peers

Countries citing papers authored by P Fitscha

Since Specialization

Citations

This map shows the geographic impact of P Fitscha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Fitscha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Fitscha more than expected).

Fields of papers citing papers by P Fitscha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Fitscha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Fitscha. The network helps show where P Fitscha may publish in the future.

Co-authorship network of co-authors of P Fitscha

This figure shows the co-authorship network connecting the top 25 collaborators of P Fitscha. A scholar is included among the top collaborators of P Fitscha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Fitscha. P Fitscha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prostaglandin E 1 decreases human arterial accumulation of radiolabeled apo B-containing lipoproteins in vivo 1997 ·European Journal of Clinical Pharmacology ·H Kritz, H. Sinzinger, Graziana Lupattelli, Irene Virgolini, P Fitscha, John O’Grady	4
2	PLATELET RESPONSE DURING PROSTAGLANDIN E 1 -THERAPY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS 1997 ·Thrombosis Research ·Harald Kritz, A. Oguogho, P Fitscha, J Kaliman, W. Rogatti, H. Sinzinger	2
3	Increase in In Vivo Low-Density Lipoprotein (LDL) Receptor Binding after PGE1 and 13,14-Dihydro-PGE1 Treatment in Rabbits 1993 ·Journal of Cardiovascular Pharmacology ·H. Sinzinger, Irene Virgolini, Shuren Li, (unknown), P Fitscha, Justin O’Grady	6
4	Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man. 1992 ·British Journal of Clinical Pharmacology ·H. Sinzinger, F Rauscha, John O’Grady, P Fitscha	8
5	Isradipine improves platelet function in hypertensives 1992 ·European Journal of Clinical Pharmacology ·H. Sinzinger, Irene Virgolini, F Rauscha, P Fitscha, John O’Grady	14
6	A 6-Week Double-Blind Comparison of Amlodipine and Placebo in Patients with Stable Exertional Angina Pectoris Receiving Concomitant β-Blocker Therapy 1991 ·Journal of Cardiovascular Pharmacology ·W. Klein, Veselin Mitrović, H Neuss, M. Schlepper, Giuseppe Cocco, (unknown), P Fitscha, (unknown)	5
7	Influence of a Single Dose of Calcium Channel Blockers on Platelet Function 1991 ·Platelets ·Kelly Weiss, P Fitscha, Irene Virgolini, (unknown), H. Sinzinger	5
8	Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteers 1990 ·European Journal of Clinical Pharmacology ·Irene Virgolini, P Fitscha, H. Sinzinger, H. Barth	8
9	Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease 1990 ·The Lancet ·H. Sinzinger, P Fitscha, Justin O’Grady, F Rauscha, W. Rogatti, John R. Vane	41
10	Decreased prostaglandin-I2 stability in acute myocardial infarction 1990 ·Thrombosis Research ·H. Sinzinger, P Fitscha, (unknown)	1
11	Platelet kinetics in patients with atherosclerosis 1990 ·Thrombosis Research ·H. Sinzinger, Irene Virgolini, P Fitscha	18
12	Prevalence of a shortened prostacyclin half‐life in plasma in healthy adults: Results of a screening investigation 1990 ·American Journal of Hematology ·H. Sinzinger, F Rauscha, P Fitscha, (unknown)	3
13	In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins. 1988 ·PubMed ·P Fitscha, J Kaliman, John O’Grady, H Sinzinger	4
14	Haemodynamic effects of short-term treatment with bopindolol in essential hypertension 1988 ·European Journal of Clinical Pharmacology ·P Fitscha, (unknown), (unknown), (unknown)	3
15	Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial application 1988 ·Thrombosis Research ·H. Sinzinger, John O’Grady, P Fitscha, (unknown), J Kaliman	15
16	Epoprostenol in patients with Raynaud's disease 1988 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·P Fitscha, J Kaliman, Franz Weidinger, (unknown), John Patrick O’Grady	2
17	Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue. 1987 ·PubMed ·J Kaliman, P Fitscha, Harald Barth, H Sinzinger	2
18	Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular disease 1987 ·Prostaglandins Leukotrienes and Medicine ·(unknown), P Fitscha, J Kaliman, H. Sinzinger, Bernhard A. Peskar	5
19	Scintigraphic detection of femoral artery atherosclerosis with 111-indium-labeled autologous platelets. 1984 ·PubMed ·H. Sinzinger, P Fitscha	5
20	[Side effects of roentgen contrast media injections with and without antihistaminics]. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), G. Seidl, (unknown), (unknown), P Fitscha	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact